 |
The Journal of Neuroscience, July 21, 2004, 24(29):6482-6488; doi:10.1523/JNEUROSCI.5712-03.2004
Previous Article | Next Article 
Development/Plasticity/Repair
Cell Type-Specific Interleukin-1 Signaling in the CNS
Deepak Srinivasan,1
Jui-Hung Yen,1
Donald J. Joseph,2 and
Wilma Friedman1
1Department of Biological Sciences, Rutgers University, Newark, New Jersey 07102, and 2Center for Neurobiology and Behavior, Columbia University, New York, New York 10032
Interleukin-1 (IL-1 ) is a potent and pleiotropic inflammatory cytokine that is highly produced in the CNS under conditions of damage, disease, or stress. This cytokine acts on CNS glia to effect inflammatory responses, mediated in part via activation of the nuclear factor- B (NF- B) transcription factor, and consequent induction of numerous cytokines. Neurons as well as astrocytes in the hippocampus also express the type 1 IL-1 receptor, indicating that this cytokine can influence neuronal function directly, yet IL-1 does not induce production of cytokines in neurons as it does in glia. In contrast, IL-1 regulates synaptic function of hippocampal neurons. Here we demonstrate that different signaling pathways mediate IL-1 actions in neurons as compared with astrocytes. IL-1 activates the p38 mitogen-activated protein kinase (MAPK) signaling pathway and induces the activation of CREB in hippocampal neurons, in contrast to the activation of NF- B in hippocampal astrocytes, demonstrating cell type-specific signaling responses to IL-1 in the brain and yielding distinct functional responses.
Key words: interleukin-1; neurons; astrocytes; NF- B; p38 MAPK; signal transduction
Received Dec 26, 2003;
revised June 7, 2004;
accepted June 9, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
E. E. McCandless, M. Budde, J. R. Lees, D. Dorsey, E. Lyng, and R. S. Klein
IL-1R Signaling within the Central Nervous System Regulates CXCL12 Expression at the Blood-Brain Barrier and Disease Severity during Experimental Autoimmune Encephalomyelitis
J. Immunol.,
July 1, 2009;
183(1):
613 - 620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ramesh, J. T. Borda, J. Dufour, D. Kaushal, R. Ramamoorthy, A. A. Lackner, and M. T. Philipp
Interaction of the Lyme Disease Spirochete Borrelia burgdorferi with Brain Parenchyma Elicits Inflammatory Mediators from Glial Cells as Well as Glial and Neuronal Apoptosis
Am. J. Pathol.,
November 1, 2008;
173(5):
1415 - 1427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Volosin, C. Trotter, A. Cragnolini, R. S. Kenchappa, M. Light, B. L. Hempstead, B. D. Carter, and W. J. Friedman
Induction of Proneurotrophins and Activation of p75NTR-Mediated Apoptosis via Neurotrophin Receptor-Interacting Factor in Hippocampal Neurons after Seizures
J. Neurosci.,
September 24, 2008;
28(39):
9870 - 9879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Sama, D. M. Mathis, J. L. Furman, H. M. Abdul, I. A. Artiushin, S. D. Kraner, and C. M. Norris
Interleukin-1{beta}-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT Activity
J. Biol. Chem.,
August 8, 2008;
283(32):
21953 - 21964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Fogal, J. Li, D. Lobner, L. D. McCullough, and S. J. Hewett
System xc Activity and Astrocytes Are Necessary for Interleukin-1{beta}-Mediated Hypoxic Neuronal Injury
J. Neurosci.,
September 19, 2007;
27(38):
10094 - 10105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Beskina, A. Miller, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina
Mechanisms of interleukin-1beta-induced Ca2+ signals in mouse cortical astrocytes: roles of store- and receptor-operated Ca2+ entry
Am J Physiol Cell Physiol,
September 1, 2007;
293(3):
C1103 - C1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Guo, H. Wang, M. Watanabe, K. Shimizu, S. Zou, S. C. LaGraize, F. Wei, R. Dubner, and K. Ren
Glial-Cytokine-Neuronal Interactions Underlying the Mechanisms of Persistent Pain
J. Neurosci.,
May 30, 2007;
27(22):
6006 - 6018.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|